Rinvoq (upadacitinib)

pCPA File Number: 21574
Negotiation Status:
Under consideration for negotiation
Indication(s):
Psoriatic Arthritis
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
SR0658-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable